Evolent Health (EVH) Current Assets (2015 - 2026)

Evolent Health's Current Assets history runs 12 years deep, the most recent figure standing at $502.0 million for Q1 2026.

• On a quarterly basis, Current Assets fell 31.04% year-over-year to $502.0 million in Q1 2026; TTM through Mar 2026 was $502.0 million, a 31.04% decrease from a year earlier, with the FY2025 full-year figure at $506.4 million, down 16.59% from the prior year.
• Current Assets fell to $502.0 million in Q1 2026 per EVH's latest filing, from $506.4 million in the prior quarter.
• Across five years, Current Assets topped out at $727.9 million in Q1 2025 and bottomed at $393.8 million in Q3 2022.
• The 5-year median for Current Assets is $544.0 million (2024), against an average of $549.6 million.
• Across the five-year window, Current Assets surged 62.22% in 2023 and sank 31.04% in 2026, its largest moves.
• Year by year, Current Assets stood at $478.1 million in 2022, then surged by 43.01% to $683.7 million in 2023, then retreated by 11.2% to $607.1 million in 2024, then declined by 16.59% to $506.4 million in 2025, then retreated by 0.86% to $502.0 million in 2026.
• Per Business Quant, the three latest EVH Current Assets figures stand at $502.0 million (Q1 2026), $506.4 million (Q4 2025), and $570.1 million (Q3 2025).